SCHEMBL21996251

SCHEMBL21996251

[2H]C([2H])([2H])C(C=O)(CO[Si](C)(C)C(C)(C)C)C([2H])([2H])[2H]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL351046 0.88
SCHEMBL31165398 0.72
SCHEMBL1601699 0.72 DUT (0.36)
SCHEMBL1601589 0.69 DUT (0.41)
SCHEMBL223474 0.68
SCHEMBL22689310 0.67
SCHEMBL28662677 0.67 GAA (0.34)
SCHEMBL2142743 0.67 DUT (0.39)
SCHEMBL2152288 0.67 CYP2C19 (0.32)
SCHEMBL5081792 0.67 TSHR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230107216-A1 PANTETHEINE DERIVATIVES AND USES THEREOF VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC. (CH) 2023-04-06 US disclosed
EP-3887353-A1 PANTETHEINE DERIVATIVES AND USES THEREOF Comet Therapeutics, Inc. (US) 2021-10-06 EP disclosed
WO-2020113209-A1 PANTETHEINE DERIVATIVES AND USES THEREOF COMET THERAPEUTICS, INC. (US) 2020-06-04 WO disclosed